Published on 9 Nov 2021 on Simply Wall St. via Yahoo Finance
Kymera Therapeutics (NASDAQ:KYMR) shareholder returns have been respectable, earning 48% in 1 year
The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. To wit, the Kymera Therapeutics, Inc. (NASDAQ:KYMR) share price is 48% higher than it was a year ago, much better than the market return of around 32% (not including dividends) in the same period. That's a solid performance by our standards! Kymera Therapeutics hasn't been listed for long, so it's still not clear if it is a long term winner.
The past week has proven to be lucrative for Kymera Therapeutics investors, so let's see if fundamentals drove the company's one-year performance.
Check out our latest analysis for Kymera Therapeutics